Cipla

Cipla rises 2% amid buzz over Bain Capital, Dr Reddy’s joint bid for promoter stake

Shares of Cipla opened over 2 percent higher on September 5 as reports said that private equity firm Bain Capital was in talks with Dr Reddy`s Laboratories to explore a joint bid to buy out the promoter’s stake in the drugmaker. At 09.31 am, shares of Cipla were trading 1.5 percent higher at Rs 1,258 …

Cipla rises 2% amid buzz over Bain Capital, Dr Reddy’s joint bid for promoter stake Read More »

Torrent Pharma joins race to acquire Hamied family stake in Cipla

Pharmaceutical company Torrent Pharma has entered the fray to acquire the Hamied family stake in Cipla in what could be the biggest pharmaceutical deal since 2014. (2.3x) combined revenue in fiscal 2023, 2.3 times earnings and 1.46 times current market value, according to a report. More importantly, the Hamied family’s competition to buy Cipla shares …

Torrent Pharma joins race to acquire Hamied family stake in Cipla Read More »

Cipla shares fall after FDA suspends license of Patalganga unit for 10 days

Cipla shares fell more than 1% in early trading on August 17 after the Konkan Food and Drug Administration (FDA) ordered the suspension of the license granted to the company’s Patalganga production unit for 10 days. in December 2023. The order was the result of non-compliance with good manufacturing practices at said facility under the …

Cipla shares fall after FDA suspends license of Patalganga unit for 10 days Read More »

Cipla zooms 9% on stronger-than-expected Q1; brokerages cheer, raise targets

Shares of major pharmaceutical company Cipla rose nearly 9% in early trading on July 27 after the company’s earnings for the April-June period beat expectations. Some brokerages also raised their price targets on the stock as they applauded the company’s impressive numbers for the quarter under review. While the company’s net income and revenue for …

Cipla zooms 9% on stronger-than-expected Q1; brokerages cheer, raise targets Read More »